Medtronic– tag –
-
Abbott and Medtronic Announce Global Partnership to Integrate FreeStyle Libre CGM Technology into Medtronic Insulin Delivery Systems
Abbott (via Facebook press release), Medtronic USA Overview Medtronic and Abbott have announced a global partnership to integrate Abbott's FreeStyle Libre sensing technology into Medtronic's insulin delivery systems. Under this agreement... -
Medtronic Launches Simplera Sync CGM Sensor in South Korea, Streamlining Glucose Management for MiniMed 780G Users
KBR South Korea Overview Medtronic has launched its Simplera Sync Sensor, a new continuous glucose monitoring (CGM) device, in South Korea for users of the MiniMed 780G automated insulin delivery (AID) system. This all-in-one disposable ... -
Dexcom G7 Achieves Industry-Leading Accuracy with MARD 8.2-8.5% in Adults, Clinical Data Confirms
diabetesknow.com USA Overview Newly compiled clinical data for 2026 ranks the Dexcom G7 as the most accurate continuous glucose monitor (CGM), reporting a mean absolute relative difference (MARD) of approximately 8.2–8.5% in adults. This... -
Medtronic Simplifies Diabetes Management with Integrated MiniMed 780G and Simplera Sync™ Sensor
Southeast Diabetes Inc. USA Overview Medtronic has introduced a state-of-the-art diabetes management solution, pairing its MiniMed 780G insulin pump system with the Simplera Sync™ sensor. Simplera Sync™ is an all-in-one, disposable conti... -
Medtronic Introduces Instinct Sensor, Expands MiniMed 780G System to Type 2 Diabetes with Dual FDA Clearances
Simply Wall St USA Overview Medtronic has expanded its diabetes sensor portfolio with the launch of the Instinct sensor, complementing its Simplera Sync™ and Guardian™ 4 sensors. The company also secured two key U.S. FDA regulatory miles... -
Dexcom G7 15-Day Continuous Glucose Monitor Authorized by Health Canada, Stelo CGM Cleared for Pediatric OTC Use by U.S. FDA
Business Wire, MarketScreener, CureCapture, Oura Member Care USA, Canada Overview Dexcom's G7 15-day continuous glucose monitoring (CGM) system has received Health Canada authorization for adults aged 18 and older, extending wear time to... -
CNET Names Dexcom Stelo, Abbott FreeStyle Libre 3 Plus, and Eversense 365 as Top Continuous Glucose Monitors for 2026, Setting New Standards in Blood Sugar Management
CNET USA Overview CNET's 2026 review identifies Dexcom Stelo, Abbott FreeStyle Libre 3 Plus, and Eversense 365 as leading continuous glucose monitoring (CGM) devices. These systems excel in sensor life, accuracy, and FDA approval status,... -
Medtronic Spins Off Diabetes Business as MiniMed Group, Reshapes Medtech Strategy with AI and Automation Focus
Stock Titan USA Overview Medtronic is strategically realigning its global medical technology business, completing the spin-off of its diabetes operating unit as 'MiniMed Group, Inc.' through an IPO in March 2026. The company is now shapi... -
Medtronic Enhances MiniMed 780G AID System with New CGM Sensors and Launches Screenless MiniMed Flex Pump
diaTribe.org USA Overview Medtronic has introduced two new continuous glucose monitor (CGM) sensors for its MiniMed 780G automated insulin delivery (AID) system in the U.S.: the 6-day Simplera Sync and the 15-day Instinct (based on Abbot...
1